Before Stryker, Wells had 17 years of senior accounting and financial management experience, holding finance leadership roles at Dialight Corporation and Johnson & Johnson. He graduated from Bucknell ...

Stryker plans to sell its U.S. spinal implants business, the company said Jan. 28. The U.S. spine segment will be sold to investment firm Viscogliosi Brothers, and that group will create VB Spine, ...

Regarding its outlook, Stryker logged expects organic sales growth of 8% to 9% for 2025, and adjusted earnings of $13.45 to $13.70 a share, as it sees sustained levels of procedural volumes and strong ...

Stryker stock dipped late Tuesday after the medtech company beat forecasts, but announced its plan to divest the U.S. spinal ...

Stryker has agreed to sell its U.S. spinal implants business to Viscogliosi Brothers to create a newly formed company called VB Spine. The medical technology company said Tuesday the New York ...

Stryker beat estimated earnings by 4.0%, reporting an EPS of $4.01 versus an estimate of $3.87. Revenue was up $621.00 million from the same period last year.

“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company," said Kevin A. Lobo, Chair and Chief Executive Officer, ...

Stryker SYK released its Q4 earnings on Tuesday, January 28, 2025 at 04:05 PM. Here's what's important from the earnings announcement. Stryker beat estimated earnings by 4.0%, reporting an EPS of ...

Stryker Corporation SYK is scheduled to release fourth-quarter 2024 results on Jan. 28, after market close. In the last reported quarter, the company delivered an earnings surprise of 3.24%. Stay ...

Stryker Corporation's innovation and market leadership justify a premium. See why SYK stock is a solid hold with long-term ...

is being acquired for $4.9 billion by global medical technology company Stryker Corp. Stryker on Jan. 6 announced an agreement to acquire the Irvine-based company for $80 per each share, kicking off ...